Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06965803

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cedars-Sina Medical Center

Los Angeles, California, 90048, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18 or older
  • diagnosed with Type 1 or Type 2 Diabetes who are on insulin
  • able to speak and understand English language
  • scheduled to receive a standard inpatient diabetes education consultation
  • must not have used CGM in the six months prior to admission
  • owns a smartphone
  • demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

Exclusion criteria

  • those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
  • non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

Treatment and study plan

Primary outcomes

  1. Patient Satisfaction (using a 5-point likert scale)

    Time frame: 15 days

    Glucose Monitoring Satisfaction Survey

Study contacts

Contact information is provided by the study sponsor or research team.

Mathew P Monterola, Doctor of Nursing Practice

CONTACT

[email protected]

3109677434

Sponsors and collaborators

Lead sponsor

Cedars-Sinai Medical Center

Other

Registry information

Official study title

Continuous Glucose Monitor (CGM) Discharge Program

Acronym: CGM QOL

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 11, 2025
Registry last updated
Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.